These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 12764231)

  • 21. Brain attack. Acute therapeutic intervention. Antithrombotic and antiplatelet-aggregating drugs.
    Adams HP; Leira EC
    Neurosurg Clin N Am; 1997 Apr; 8(2):207-17. PubMed ID: 9113702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serial change in platelet activation markers with aspirin and clopidogrel after acute ischemic stroke.
    Tsai NW; Chang WN; Shaw CF; Jan CR; Chang HW; Huang CR; Chen SD; Chuang YC; Lee LH; Lu CH
    Clin Neuropharmacol; 2010; 33(1):40-5. PubMed ID: 19855266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiplatelet therapy in combination with rt-PA thrombolysis in ischemic stroke (ARTIS): rationale and design of a randomized controlled trial.
    Zinkstok SM; Vermeulen M; Stam J; de Haan RJ; Roos YB
    Cerebrovasc Dis; 2010; 29(1):79-81. PubMed ID: 19907167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antithrombotic strategy in stroke.
    Bousser MG
    Thromb Haemost; 2001 Jul; 86(1):1-7. PubMed ID: 11486994
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.
    Baumann CR; Baumgartner RW; von Büdingen HC; Rousson V; Siegel AM; Georgiadis D
    Cerebrovasc Dis; 2007; 24(1):127-9. PubMed ID: 17565198
    [No Abstract]   [Full Text] [Related]  

  • 26. Heparin vs aspirin in acute ischaemic stroke.
    Pereira AC; Warburton E
    Lancet; 2000 Jul; 356(9223):73. PubMed ID: 10892787
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
    Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
    Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial.
    Sprigg N; Gray LJ; Bath PM; Lindenstrøm E; Boysen G; De Deyn PP; Friis P; Leys D; Marttila R; Olsson JE; O'Neill D; Ringelstein EB; van der Sande JJ; Turpie AG;
    J Stroke Cerebrovasc Dis; 2007; 16(4):180-4. PubMed ID: 17689415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome.
    Derksen RH; de Groot PG; Kappelle LJ
    Neurology; 2003 Jul; 61(1):111-4. PubMed ID: 12847169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Management of acute ischaemic stroke.
    Al Mahdy H
    Br J Hosp Med (Lond); 2009 Oct; 70(10):572-7. PubMed ID: 19966702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The treatment of acute ischemic stroke].
    Csiba L
    Orv Hetil; 2004 Nov; 145(45):2297-301. PubMed ID: 15573895
    [No Abstract]   [Full Text] [Related]  

  • 32. Antiplatelets and stroke outcomes: state of the science.
    Meyer D
    Crit Care Nurs Clin North Am; 2009 Dec; 21(4):517-28. PubMed ID: 19951767
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
    Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiplatelet drugs for ischemic stroke prevention.
    Leys D; Balucani C; Cordonnier C
    Cerebrovasc Dis; 2009; 27 Suppl 1():120-5. PubMed ID: 19342841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The stroke pharmacopeia: current medical therapies.
    Wittkowsky AK
    Pharmacotherapy; 1998; 18(3 Pt 2):94S-100S; discussion 85S-86S. PubMed ID: 9619493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current practice of antithrombotic treatment in ischemic stroke: a survey among Hungarian neurologists.
    Sztriha LK; Vécsei L
    Ideggyogy Sz; 2008 May; 61(5-6):148-54. PubMed ID: 18567389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet aggregating versus anticoagulant agents in preventing early recurrent stroke among patients with atrial fibrillation.
    Adams HP
    Curr Neurol Neurosci Rep; 2001 Jan; 1(1):11-2. PubMed ID: 11898494
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-molecular-weight heparin in atherosclerotic stroke: a surprising resurrection of anticoagulants?
    Bang OY; Kim JS
    Stroke; 2012 Feb; 43(2):293-4. PubMed ID: 22076003
    [No Abstract]   [Full Text] [Related]  

  • 39. Unfractionated heparin is associated with a lower rise of serum vascular cell adhesion molecule-1 in acute ischemic stroke patients.
    Chamorro A; Cervera A; Castillo J; Dávalos A; Aponte JJ; Planas AM
    Neurosci Lett; 2002 Aug; 328(3):229-32. PubMed ID: 12147313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nadroparin plus aspirin versus aspirin alone in the treatment of acute ischemic stroke.
    Sarma GR; Roy AK
    Neurol India; 2003 Jun; 51(2):208-10. PubMed ID: 14571005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.